Despite its seemingly low frequency, FLT3 amplification shouldn’t be overlooked, especially considering its broader presence in other solid tumors such as gastric cancers, lung adenocarcinomas, and breast cancers (24). The gene discussed is FLT3; the disease is lung adenocarcinoma.